期刊文献+

合理应用喹诺酮类抗菌药物 被引量:13

Rational use of quinolones antibiotics
原文传递
导出
摘要 目的了解喹诺酮类抗菌药物的作用机制,不良反应及使用时的注意事项。方法对喹诺酮类抗菌药物在临床使用中的注意事项及所涉及的不良反应进行汇总。结果随着临床使用喹诺酮类抗菌药物的增加,药物的不良反应也随着上升,其不良反应发生率〈2.0%,肾损害的发生率为0.9%~4.3%。结论在广泛应用喹诺酮类抗菌药物的同时,要更多地关注其安全性。 OBJECTIVE To understand the mechanism of quinolones, adverse reactions and precautions when using. METHODS The precautions of quinolones in clinical use and the adverse reactions involved were aggregated. RESULTS With the increased clinical use of quinolones, the incidence of adverse drug reactions was increased more than 〈2.0%. CONCLUSION In the widely use of quinolones antibiotics, their safety should be more concerned about.
作者 宋惠珠
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第5期951-952,共2页 Chinese Journal of Nosocomiology
关键词 合理用药 喹诺酮类 抗菌药物 Rational use of drugs Quinolones Antibiotic
  • 相关文献

参考文献3

二级参考文献21

  • 1谢红刚,封宇飞,邹忠梅.新一代广谱氟喹诺酮类抗菌药吉米沙星[J].中国新药杂志,2005,14(3):353-355. 被引量:9
  • 2高钧.氟喹诺酮类药物的临床应用进展[J].中国临床药理学杂志,2005,21(3):229-232. 被引量:20
  • 3刘梦佳.下呼吸道感染病人氟喹诺酮类药物的选择指南[J].国外医学(药学分册),2006,33(2):134-136. 被引量:6
  • 4Appelbaum PC, Gillespie SH, Burley CJ, et al. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st Century: a review of gemifloxaein[J]. Int J Antimierob Agents,2004,23(6) :533-546.
  • 5Grossman RF,Rotschafer JC, Tan JS. Antimicrobial treatment of lower respiratory tract infections in the hospital setting[J]. Am J Med,2005,118(7A) : 29S-38S.
  • 6Lionel A, Mandell, Richard G,et al. Infectious Disease Society of Amercian/Amereian Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[s]. Clin Infect Dis, 2007,44 : S27-S72.
  • 7Gotfried MH. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999- 2000 respiratory surveillance program[J]. Am J Med,2001,111(9A) :25S-29S; discussion 36S-38S.
  • 8Frank E, Liu J, Kinasewitz G, et al. A multicenter, open-label, randomized comparison of levofloxaein and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia[J]. Clin Ther, 2002,24 (8): 1292-1308.
  • 9File TM Jr,Milkovich G,Tennenberg AM,et al. Clinical implications of 750 rag, 5-day levofloxacin for the treatment of community-acquired pneumonia[J]. Curr Med Res Opin, 2004,20(9) : 1473-1481.
  • 10Dunbar LM,Khashab MM,Kahn JB,et al. Efficacy of 750 mg, 5 day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens[J]. Curr Med Res Opin,2004,20 (4) :555-563.

共引文献4

同被引文献82

  • 1孙晶.喹诺酮类药物的临床应用及不良反应[J].黑龙江医学,2004,28(5):379-380. 被引量:1
  • 2白汉玉,孙金苹.呼吸道疾病 第7讲 呼吸道感染抗生素的合理应用[J].中国农村医学,2004,32(10):24-25. 被引量:8
  • 3孟拥军,朱蓓德.191例抗菌药物不良反应报告回顾性分析[J].中国药物警戒,2006,3(1):33-35. 被引量:19
  • 4黄玫 王丹丹.氟喹诺酮类药物不良反应与发生机制的研究进展.长春医学,2009,7(4):60-62.
  • 5国家药品不良反应监测中心,国家食品药品监督管理局药品评价中心.百时美施贵宝公司决定从市场撤出加替沙星[J].药物警戒快评,2006,19:8.
  • 6Basaran NF, Akici A. Patients' experience and perspectives on the rational use of drugs in Turkey: a survey study. Patient Prefer Adherence, 2012, 6: 719-724.
  • 7Ahmed SM, Islam QS. Availability and rational use of drugs in primary healthcare facilities following the national drug policy of 1982: isBangladesh on right track? J Health Popul Nutr, 2012, 30 ( 1 ) ." 99-108.
  • 8Medeiros EF, Moraes CF, Karnikowski M, et al. An interdisciplinary intervention as a strategy for Rational Use of Drugs by the elderly. Cien Saude Colet, 2011, 16 (7):3139-3149.
  • 9Ray K, Sarkar PK, Roy K. Assessment of the need for a training course in rational use of drugs: a cross-sectional pilot study. J Indian Med Assoc, 97 (12) : 496-499.
  • 10Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol, 1991, 44 Suppl 2: 57S-65S.

引证文献13

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部